Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Houlihan Lokey Appoints Scott Adelson as New CEO

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finance_Assets
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Houlihan Lokey, a well-known financial services firm, has recently announced the appointment of Scott Adelson as its new Chief Executive Officer, taking over from Scott Beiser. This leadership transition signifies a significant change within the company.

Scott Adelson will be stepping into the role of CEO, bringing his expertise and innovative vision to guide the organization into the future. This shift in leadership structure reflects a strategic decision by Houlihan Lokey, with Adelson now at the helm.

As the new CEO, Adelson is expected to continue the company’s growth and maintain its reputation as a key player in the financial services industry. This change marks a new chapter for Houlihan Lokey under Adelson’s leadership.

HLI Stock Price Update: March 4, 2024 Analysis and Potential for Long-Term Growth

On March 4, 2024, HLI stock experienced a slight drop in its price, closing at $125.86. This represents a decrease of $1.38 or 1.08% since the previous market close. Despite this drop, HLI is still trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong performance in the long term. Investors should keep an eye on any upcoming news or developments related to HLI that could potentially impact its stock performance. Overall, while HLI stock may have experienced a slight drop on March 4, its strong performance relative to its 52-week range and moving average suggest that it may still hold potential for long-term growth. Investors should continue to monitor the stock closely and stay informed about any developments that could impact its performance in the future.

HLI Stock Financial Performance Analysis: March 4, 2024

On March 4, 2024, investors in HLI stock may have been closely monitoring the company’s financial performance. The data shows that HLI’s total revenue for the past year was $1.81 billion, with a significant decrease of 20.27% compared to the previous year. However, there was a slight increase of 9.56% in total revenue since the last quarter, which could be seen as a positive sign of growth.

Similarly, HLI’s net income for the past year was reported at $254.22 million, showing a decrease of 41.93% since the previous year. On a more positive note, there was a 5.63% increase in net income since the last quarter, indicating a potential turnaround in profitability.

Earnings per share (EPS) for HLI stood at $3.76 for the past year, reflecting a 41.35% decrease compared to the previous year. However, there was a 5.6% increase in EPS since the last quarter, suggesting that the company may be making efforts to improve its bottom line.

Overall, the data on HLI’s financial performance on March 4, 2024, indicates a mixed bag of results. While there were significant declines in total revenue, net income, and EPS compared to the previous year, the positive growth since the last quarter could be a promising sign for investors. It will be interesting to see how HLI continues to navigate these challenges and capitalize on any opportunities for growth in the future.

Tags: HLI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Tech-banking-finance

Paymentus Holdings NYSE PAY Surpasses Q4 Earnings Expectations

Electric Utilities Markets and money

Tanya MonizWitten Appointed President of San Jose Water

Biotechnology Stock Bull Market

Akoya Biosciences Projects Strong Revenue Growth and Operating Cash Flow Breakeven by 2024

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com